Evidence map›Paper›PMID 27900789›Full record

ArticleGenetic epidemiology2017

A general approach to testing for pleiotropy with rare and common variants.

Sharon M Lutz, Tasha E Fingerlin, John E Hokanson, Christoph Lange

Abstract readComparative StudyMulticenter Study
In one paragraph

Article in Genetic epidemiology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed.

  1. Review
  2. Joint analysis ofNAR genomics and bioinformatics · 2025
    Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Genetic Advances in Chronic Obstructive Pulmonary Disease. Insights from COPDGene.American journal of respiratory and critical care medicine · 2019
    Review
  11. Article
  12. Article
  13. Review
  14. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Sharon M LutzDepartment of Biostatistics, University of Colorado, Anschutz Medical Campus, Aurora, CO, USA.
Tasha E FingerlinDepartment of Biostatistics, University of Colorado, Anschutz Medical Campus, Aurora, CO, USA.
John E HokansonDepartment of Epidemiology, University of Colorado, Anschutz Medical Campus, Aurora, CO, USA.
Christoph LangeDepartment of Biostatistics, Harvard T.H. Chan School of Public Health, Boston, MA, USA.

Funding

Genetic Epidemiology of COPDU01HL089897 · NHLBI · NATIONAL JEWISH HEALTH · PI CRAPO, JAMES D · 2007 to 2021
$56.9M
Metabolomic signatures of empysema and COPD progression in the COPDGene cohortR01HL089897 · NHLBI · NATIONAL JEWISH HEALTH · PI CRAPO, JAMES D · 2012 to 2016
$31.1M
Genetic Epidemiology of COPDU01HL089856 · NHLBI · BRIGHAM AND WOMEN'S HOSPITAL · PI SILVERMAN, EDWIN K · 2007 to 2021
$20.7M
(2 of 2) Genetic Epidemiology of COPDR01HL089856 · NHLBI · BRIGHAM AND WOMEN'S HOSPITAL · PI SILVERMAN, EDWIN K · 2012 to 2016
$18.9M
Common Genetic Pathways Underlying CVD and COPDK01HL125858 · NHLBI · UNIVERSITY OF COLORADO DENVER · PI LUTZ, SHARON MARIE · 2015 to 2019
$721k
Integrating linkage information in tests of association for rare variants in ILDR21HL113543 · NHLBI · UNIVERSITY OF COLORADO DENVER · PI FINGERLIN, TASHA E. · 2013 to 2014
$382k
NHLBI NIH HHS K01 HL125858NHLBI NIH HHS R01 HL089856NHLBI NIH HHS R01 HL089897NHLBI NIH HHS R21 HL113543NHLBI NIH HHS U01 HL089856NHLBI NIH HHS U01 HL089897
6 · The paper itself

Abstract

Through genome-wide association studies, numerous genes have been shown to be associated with multiple phenotypes. To determine the overlap of genetic susceptibility of correlated phenotypes, one can apply multivariate regression or dimension reduction techniques, such as principal components analysis, and test for the association with the principal components of the phenotypes rather than the individual phenotypes. However, as these approaches test whether there is a genetic effect for at least one of the phenotypes, a significant test result does not necessarily imply pleiotropy. Recently, a method called Pleiotropy Estimation and Test Bootstrap (PET-B) has been proposed to specifically test for pleiotropy (i.e., that two normally distributed phenotypes are both associated with the single nucleotide polymorphism of interest). Although the method examines the genetic overlap between the two quantitative phenotypes, the extension to binary phenotypes, three or more phenotypes, and rare variants is not straightforward. We provide two approaches to formally test this pleiotropic relationship in multiple scenarios. These approaches depend on permuting the phenotypes of interest and comparing the set of observed P-values to the set of permuted P-values in relation to the origin (e.g., a vector of zeros) either using the Hausdorff metric or a cutoff-based approach. These approaches are appropriate for categorical and quantitative phenotypes, more than two phenotypes, common variants and rare variants. We evaluate these approaches under various simulation scenarios and apply them to the COPDGene study, a case-control study of chronic obstructive pulmonary disease in current and former smokers.

Indexed as

Models, GeneticAgedAged, 80 and overCase-Control StudiesFemaleGenetic MarkersGenetic PleiotropyGenetic Predisposition to DiseaseGenome-Wide Association StudyHumansMaleMiddle AgedPhenotypePolymorphism, Single NucleotidePulmonary Disease, Chronic ObstructiveQuantitative Trait LociGenetic MarkersGWASpleiotropyqualitative phenotypesquantitative phenotypesrare variant analysis

Identifiers

PMID27900789
PMCPMC5472207

What Socratic holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.